trimethoprim has been researched along with Infection, Mycobacterium avium-intracellulare in 3 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twelve lipophilic 2,4-diamino-5-methyl-5-deazapteridine derivatives and trimethoprim were evaluated for activity against Mycobacterium tuberculosis and Mycobacterium avium in vitro." | 3.70 | Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase. ( Barrow, EW; Barrow, WW; Piper, JR; Reynolds, RC; Suling, WJ; Wilson, LN, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raszka, WV | 1 |
| Skillman, LP | 1 |
| McEvoy, PL | 1 |
| Suling, WJ | 1 |
| Reynolds, RC | 1 |
| Barrow, EW | 1 |
| Wilson, LN | 1 |
| Piper, JR | 1 |
| Barrow, WW | 1 |
| Asencio Marchante, R | 1 |
| Lissen Otero, E | 1 |
3 other studies available for trimethoprim and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
In vitro susceptibility of clinical isolates of Mycobacterium avium and M. intracellulare to folate antagonists.
Topics: Adult; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Drug | 1994 |
Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase.
Topics: Animals; Cell Survival; Chlorocebus aethiops; Folic Acid Antagonists; Humans; Microbial Sensitivity | 1998 |
[Secondary prevention of opportunistic infections in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal A | 2001 |